Showing results (271-280 of 371) with videos related to
Sort By:
Pageof 38
Journal of Autism and Developmental Disorders|May 6, 2025
Autism and Dementia: A Summative Report from the 2nd International Summit on Intellectual Disabilities and DementiaM P Janicki, P McCallion, N Jokinen, et al.International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Outcomes of proton therapy for the treatment of uveal metastasesSophia C Kamran, John M Collier, Anne Marie Lane, et al.Practical Radiation Oncology|May 1, 2018
The role of proton beam therapy in central neurocytoma: A single-institution experienceKylie H Kang, Emily Schapira, Andrzej Niemierko, et al.Medicine and Science in Sports and Exercise|July 15, 1998
Activity Counseling Trial (ACT): rationale, design, and methods. Activity Counseling Trial Research GroupS N Blair, W B Applegate, A L Dunn, et al.Environmental Health Perspectives|November 2, 2010
Ambient particulate matter air pollution and venous thromboembolism in the Women's Health Initiative Hormone Therapy trialsRegina A Shih, Beth Ann Griffin, Nicholas Salkowski, et al.American Journal of Clinical Oncology|February 7, 2020
ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation TherapyHelen A Shih, Ramesh Rengan, Smith Apisarnthanarax, et al.Neuro-Oncology Practice|July 15, 2024
Controversies in neuro-oncology: Focal proton versus photon radiation therapy for adult brain tumorsDanielle B P Eekers, Catharina M L Zegers, Kamran A Ahmed, et al.Current Oncology (Toronto, Ont.)|March 28, 2023
Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case SeriesJules P J Douwes, Kimberley S Koetsier, Victor S van Dam, et al.Journal of Neurosurgery|June 17, 2017
Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomasDaniel Kim, Andrzej Niemierko, William L Hwang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinicA M Martin, M A Blackwood, D Antin-Ozerkis, et al.Pageof 38